Clinical trial · Observational
Discovering Cancer Risks From Environmental Contaminants and Maternal/Child Health
DREAM: Discovering Cancer Risks From Environmental Contaminants And Maternal/Child Health
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Why stopped (as posted): Collaborating funding sponsor decision
Summary
Brief summary (as posted)
The DREAM Cohort is a longitudinal observational study developed to enhance our understanding of how multiple exposures to environmental chemicals and pollutants across a diverse population of pregnant women and their offspring are linked to cancer risks. Because pregnancy induces multiple maternal hormonal and physiological changes that can increase cancer susceptibility to environmental chemical exposures, this study will focus on pregnancy as a period of particular vulnerability to toxic agents.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Cancer | Malignant Neoplasm | ALIAS | 0.90 |
Interventions
Interventions (2)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Health Questionnaires | Other | — | UNRESOLVED |
| Specimen sample collection | Other | — | UNRESOLVED |
Design
Arms and outcomes
Arms (1)
- label
- Pregnant women and their children
- description
- The DREAM cohort will recruit from University of California, San Francisco (UCSF) Mission Bay, Zuckerberg San Francisco General Hospital, and Fresno Community Medical Center locations to enroll an economically, geographically, ethnically and racially diverse cohort of pregnant women and their children for long term follow-up.
- interventionNames
- Other: Health Questionnaires
- Other: Specimen sample collection
Primary outcomes (5)
- measure
- Assessment of levels of consumer product-related chemicals
- timeFrame
- Up to 4 years
- description
- Consumer product related chemicals measured via biomonitoring of polyfluoroalkyl substances (PFAS), phthalates and other plasticizers, phenolic compounds, pesticides, and aromatic amines will be assessed.
- measure
- Evaluation of endocrine system disruptions
- timeFrame
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
Show eligibility criteria text
Inclusion Criteria: * Pregnant women, over the age of 18 years. * English or Spanish-speaking. * Children born of participants enrolled during pregnancy will be enrolled in the DREAM cohort. * Inclusion criterion for the DREAM Cohort Ambassador Program is limited to research participants in the DREAM Cohort. Exclusion Criteria: * Women under the age of 18. * Women expecting the birth of multiples (twins, triplets, etc.).
References
Publications (0)
Data not yet available